These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24993601)

  • 1. Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.
    Kaffenberger BH; Zuo RC; Gru A; Plotner AN; Sweeney SA; Devine SM; Hymes SR; Cowen EW
    J Am Acad Dermatol; 2014 Oct; 71(4):745-53. PubMed ID: 24993601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features in patients with hepatic graft-versus-host disease.
    Chiba T; Yokosuka O; Goto S; Fukai K; Imazeki F; Kohno Y; Nishimura M; Saito Y; Saisho H
    Hepatogastroenterology; 2005; 52(66):1849-53. PubMed ID: 16334791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial chimerism in chronic sclerotic-type chronic graft-versus-host disease (GVHD) and GVHD-associated angiomatosis.
    Kaffenberger BH; Zhang E; Duncan JR; Jaglowski S; Klisovic RB; Devine SM; Wong HK; Gru AA
    Br J Dermatol; 2016 Oct; 175(4):782-4. PubMed ID: 26875995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adenotonsillectomy in graft-versus-host disease.
    Schwab B; Raynor E
    Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):57-60. PubMed ID: 22018926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-host disease-associated angiomatosis with striking lipomatous metaplasia.
    Llamas-Velasco M; Muñoz-Aceituno E; Sánchez-Pérez J; Camarero-Mulas C; Fraga J; Aragüés M
    J Cutan Pathol; 2022 Apr; 49(4):373-376. PubMed ID: 34743349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of cutaneous graft-versus-host disease after allogeneic haematopoietic cell transplantation: long-term follow-up results in a single Turkish centre.
    Sanli H; Ekmekçi P; Arat M; Gürman G
    Acta Derm Venereol; 2004; 84(4):296-301. PubMed ID: 15339075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous graft-versus-host disease incidence is similar in haploidentical and matched unrelated hematopoietic transplant recipients: A retrospective cohort study.
    Heberton MM; Tripathi S; Slade M; Trinkaus K; Romee R; Anadkat M
    J Am Acad Dermatol; 2020 Dec; 83(6):1654-1658. PubMed ID: 31689447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography.
    Gottlöber P; Leiter U; Friedrich W; Bunjes D; Schulz A; Kerscher M; Peter RU
    J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):402-7. PubMed ID: 12834449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of skin biopsy on the management of acute graft-versus-host disease in a pediatric population.
    Haimes H; Morley KW; Song H; Okhovat JP; Schmidt B; Huang JT
    Pediatr Dermatol; 2019 Jul; 36(4):455-459. PubMed ID: 31016777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
    Mielcarek M; Martin PJ; Leisenring W; Flowers ME; Maloney DG; Sandmaier BM; Maris MB; Storb R
    Blood; 2003 Jul; 102(2):756-62. PubMed ID: 12663454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
    Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
    JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
    Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
    Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
    Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Graft-versus-host disease: Review of 22 cases].
    Steels E; Meuleman N; Vereecken P; de Saint Aubain N; De Dobbeleer G; Bron D; Heenen M
    Acta Clin Belg; 2004; 59(4):182-8. PubMed ID: 15597724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous manifestations of graft versus host disease in a population of pediatric and young adults patients].
    Martino C; Calvano R; Boggio P; Scacchi MF; Sojo M; Carbajosa A; Makiya M; Giachetti A
    Arch Argent Pediatr; 2020 Oct; 118(5):e468-e475. PubMed ID: 32924403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk factors for sclerotic graft-versus-host disease.
    Inamoto Y; Martin PJ; Flowers ME; Lee SJ; Carpenter PA; Warren EH; Geraghty DE; Lee N; Boeckh MJ; Storer BE; Levine DM; Fan W; Zhao LP; Hansen JA
    Blood; 2016 Sep; 128(11):1516-24. PubMed ID: 27313329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
    Jin H; Fan Z; Huang F; Chai Y; Xuan L; Lin R; Xu N; Ye J; Sun J; Liu Q
    Infection; 2019 Apr; 47(2):275-284. PubMed ID: 30734248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.